VBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17M

• VBI Vaccines press release (NASDAQ:VBIV): FY GAAP EPS of $0.27 beats by $0.54.
• Revenue of $0.63M (-40.6% Y/Y) misses by $0.17M.
• As of December 31, 2021 cash, cash equivalents of $121.7M compared with $119.1 million in cash, cash equivalents, and short-term investments as of December 31, 2020.